Effect of Raloxifene on Serum Lipids for Type 2 Diabetic Menopausal Women with or without Statin Treatment | Zendy

Mihoko Matsumura | Zendy; Tsuyoshi Monden | Zendy; Yuki Nakatani | Zendy; Hiroaki Shimizu | Zendy; Nozomi Domeki | Zendy; Kazunori Yanagi | Zendy; Shiori Ikeda | Zendy; Yoshiaki Kawagoe | Zendy; Kikuo Kasai | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effect of Raloxifene on Serum Lipids for Type 2 Diabetic Menopausal Women with or without Statin Treatment

Author(s) -

Mihoko Matsumura,

Tsuyoshi Monden,

Yuki Nakatani,

Hiroaki Shimizu,

Nozomi Domeki,

Kazunori Yanagi,

Shiori Ikeda,

Yoshiaki Kawagoe,

Kikuo Kasai

Publication year - 2009

Publication title -

medical principles and practice

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.426

H-Index - 45

eISSN - 1423-0151

pISSN - 1011-7571

DOI - 10.1159/000252838

Subject(s) - raloxifene , medicine , endocrinology , osteoporosis , n terminal telopeptide , type 2 diabetes , statin , selective estrogen receptor modulator , triglyceride , hyperlipidemia , diabetes mellitus , cholesterol , estrogen receptor , osteocalcin , alkaline phosphatase , chemistry , biochemistry , cancer , breast cancer , enzyme

Our aim was to investigate the effect of 1-year treatment with raloxifene, a selective estrogen receptor modulator, on plasma lipid profiles in Japanese postmenopausal type 2 diabetic patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research